Connection
Stephen Daniels to Heterozygote
This is a "connection" page, showing publications Stephen Daniels has written about Heterozygote.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.631 |
|
|
|
-
Daniels S, Caprio S, Chaudhari U, Manvelian G, Baccara-Dinet MT, Brunet A, Scemama M, Loizeau V, Bruckert E. PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study. J Clin Lipidol. 2020 May - Jun; 14(3):322-330.e5.
Score: 0.631